Fractyl Health, Inc. (GUTS) has disclosed a new risk, in the Regulation category.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fractyl Health, Inc. operates under stringent U.S. and foreign anti-corruption, export, and sanctions regimes, exposing it to significant compliance risk. Any violation by its employees or third-party partners could trigger severe civil and criminal penalties, operational restrictions, and lasting reputational damage that may adversely affect its growth and financial performance.
The average GUTS stock price target is $6.00, implying 1,100.00% upside potential.
To learn more about Fractyl Health, Inc.’s risk factors, click here.